Coronary interventions
Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial November 20, 2016 | 10.4244/EIJV12I10A209